Miami has long been the global shorthand for a specific kind of aesthetic perfection: sun-drenched skin, athletic frames, and a relentless commitment to the visual. For Sidhbh and Neasa Gallagher, two sisters from County Louth, Ireland, this atmosphere isn’t just a backdrop—it is the engine of their business. Operating a private plastic surgery practice in the heart of Miami, the sisters are witnessing a profound shift in what patients want, driven by a pharmacological revolution that is reshaping the body contouring market.
The catalyst is the explosion of GLP-1 receptor agonists—the class of weight-loss drugs including semaglutide and tirzepatide. While these medications have dominated headlines for their ability to suppress appetite and induce rapid weight loss, they have created a secondary, surgical demand. For many patients, the “miracle” of the medication leaves behind a physical remnant: significant amounts of redundant, loose skin that cannot be toned away in a gym.
Sidhbh Gallagher, who trained as a plastic surgeon in the U.S. Midwest after graduating from medical school in Dublin, has seen the composition of her patient list evolve in real-time. “Weight-loss drugs have changed the face of the practice a lot,” she notes. The surge in GLP-1 use, which some estimates suggest has touched as many as one in eight people in the U.S., has turned “lifts and tucks” into the cornerstone of the modern aesthetic clinic.
The GLP-1 Pipeline: From Pharmacy to Operating Room
The economic trajectory of the aesthetic industry is increasingly tied to the pharmaceutical pipeline. In previous decades, the primary drivers of body contouring were liposuction or traditional diet-and-exercise weight loss. However, the speed and scale of weight loss associated with GLP-1 drugs often outpace the skin’s ability to retract.
This has led to a spike in “skin removal” surgeries. Tummy tucks (abdominoplasty) and arm lifts (brachioplasty) have seen a resurgence, as patients seek to align their external silhouette with their new, lower weight. According to data from the American Society of Plastic Surgeons, these procedures saw a standout year in 2024, a trend the organization attributes in part to the widespread adoption of medical weight-loss interventions.
Beyond the skin, the Gallagher practice is seeing growth in more structural modifications. Rib-remodeling—a procedure that involves repositioning or removing portions of the ribs to create a narrower waistline—is gaining traction. While historically associated with gender-affirming care, Dr. Gallagher observes that the demand is expanding among cis-gender female patients who feel their natural skeletal structure prevents them from achieving a specific aesthetic goal.
| Stage | Primary Intervention | Objective | Surgical Outcome |
|---|---|---|---|
| Phase 1: Reduction | GLP-1 Medications | Rapid weight loss | Weight stabilization |
| Phase 2: Maintenance | Botox / Fillers | Facial rejuvenation | “Gateway” aesthetic entry |
| Phase 3: Contouring | Tummy Tuck / Arm Lift | Removal of loose skin | Structural silhouette alignment |
| Phase 4: Refinement | Rib-remodeling | Waistline narrowing | Skeletal modification |
Navigating Policy and Specialization
The Gallagher practice is not solely focused on the weight-loss trend. Approximately half of Dr. Gallagher’s surgeries are related to gender reassignment. In a political climate where protections for transgender individuals have become a flashpoint of legislative debate, particularly during the Trump administration and subsequent state-level policy shifts, the independence of a private center is a strategic advantage.
Having a dedicated facility allows the sisters to hand-pick their staff and maintain a consistent, supportive environment for a patient base that often travels from across the United States to access specialized care. While Dr. Gallagher acknowledges that the national discourse is deeply polarized, she maintains that the day-to-day delivery of these essential medical services remains stable in her Miami practice.
This specialization exists alongside a broader “gateway” strategy. The proliferation of non-invasive procedures like Botox and dermal fillers has normalized cosmetic intervention. Dr. Gallagher views these as the entry point for many patients, challenging the stereotype that plastic surgery is reserved for the “deeply miserable.” Instead, she describes a patient base looking to resolve specific physical frustrations to improve their overall quality of life.
The Miami Hub and the International Slump
Miami’s status as a global hub for surgery is underpinned by its infrastructure—specifically its flight connectivity and its identity as a crossroads of the Americas. With a population where over half were born outside the U.S. And a Hispanic residency rate of approximately 71% in 2024, the city offers a cultural diversity that Dr. Gallagher finds more appealing than her previous experience in agricultural Indiana.
However, the “medical tourism” aspect of the business has faced headwinds. Dr. Gallagher has noted a decline in international patients, including those from her native Ireland. This trend suggests a broader hesitation toward long-haul travel, which may be influenced by economic volatility or a lingering post-pandemic caution.
Amidst these market shifts, the sisters have prioritized a sustainable business model. Neasa Gallagher, a former primary school teacher in Dubai, now manages the business operations. Together, they have implemented a four-day workweek—with surgery concentrated into two intensive days—to avoid the burnout common in surgical training. This balance is a deliberate departure from the “hustle culture” often associated with Miami’s high-end professional sectors.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider for information regarding GLP-1 medications or surgical procedures.
The evolution of the plastic surgery market will continue to track closely with pharmaceutical breakthroughs. As newer generations of weight-loss drugs enter the market and insurance coverage potentially expands, the demand for corrective skin surgery is expected to remain a primary growth driver for aesthetic practices through 2025. The story of the Gallagher sisters will be featured on Channel 4’s Escape to Florida on May 11th and 12th.
Do you think the rise of weight-loss drugs will permanently shift the demand for plastic surgery? Share your thoughts in the comments or share this article with your network.
